Atlas Trials

The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia

Clinical trial NCT04155242 · UNKNOWN

Trial details

NCT number
NCT04155242
Sponsor
University of Cambridge
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Barrett's Oesophagus
Start date
2020-09-01
Primary completion
2024-12-01
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.